| Full Name | Stacy Beaty |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 23 Years |
| Location | 1755 S Grand, St Louis, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669499638 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 2005004429 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Tarrant Dermatology Inc | 6002801164 | 4 |
News Archive
INVISTA and The Centre for Process Innovation (CPI) announce a collaboration for the development of new technologies to enable gas-fermentation-based processes for the production of industrial chemicals.
A new study by Weill Cornell Medical College researchers shows that adolescents' reactions to threat remain high even when the danger is no longer present. According to researchers, once a teenager's brain is triggered by a threat, the ability to suppress an emotional response to the threat is diminished which may explain the peak in anxiety and stress-related disorders during this developmental period.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the design of its planned Phase III registration clinical trial of Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega 3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Sapio Sciences is pleased to announce the release of Exemplar NGS LIMS. Sapio's NGS LIMS system will track multiple next-generation sequencing platform workflows from request through processing and analysis.
› Verified 2 days ago
| Entity Name | Northeast Tarrant Dermatology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235357666 PECOS PAC ID: 6002801164 Enrollment ID: O20040417000444 |
News Archive
INVISTA and The Centre for Process Innovation (CPI) announce a collaboration for the development of new technologies to enable gas-fermentation-based processes for the production of industrial chemicals.
A new study by Weill Cornell Medical College researchers shows that adolescents' reactions to threat remain high even when the danger is no longer present. According to researchers, once a teenager's brain is triggered by a threat, the ability to suppress an emotional response to the threat is diminished which may explain the peak in anxiety and stress-related disorders during this developmental period.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the design of its planned Phase III registration clinical trial of Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega 3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Sapio Sciences is pleased to announce the release of Exemplar NGS LIMS. Sapio's NGS LIMS system will track multiple next-generation sequencing platform workflows from request through processing and analysis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stacy Beaty, MD 3691 Rutger Ave, Provider Enrollment, St Louis, MO 63110 Ph: (314) 977-6828 | Stacy Beaty, MD 1755 S Grand, St Louis, MO 63104 Ph: (314) 256-3433 |
News Archive
INVISTA and The Centre for Process Innovation (CPI) announce a collaboration for the development of new technologies to enable gas-fermentation-based processes for the production of industrial chemicals.
A new study by Weill Cornell Medical College researchers shows that adolescents' reactions to threat remain high even when the danger is no longer present. According to researchers, once a teenager's brain is triggered by a threat, the ability to suppress an emotional response to the threat is diminished which may explain the peak in anxiety and stress-related disorders during this developmental period.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the design of its planned Phase III registration clinical trial of Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega 3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Sapio Sciences is pleased to announce the release of Exemplar NGS LIMS. Sapio's NGS LIMS system will track multiple next-generation sequencing platform workflows from request through processing and analysis.
› Verified 2 days ago
Lester Thomas Reese, MD Dermatology Medicare: Medicare Enrolled Practice Location: 522 North New Ballas Road, Suite 316, St Louis, MO 63141 Phone: 314-567-5873 Fax: 314-567-4040 | |
Madhavi Kandula, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 845 North New Ballas Court, Suite 310, St Louis, MO 63141 Phone: 314-692-0221 Fax: 314-692-0686 | |
Natalie L Semchyshyn, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1755 S Grand, St Louis, MO 63104 Phone: 314-256-3400 | |
Joseph Duvall, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1755 S Grand, St Louis, MO 63104 Phone: 314-256-3433 Fax: 214-256-3431 | |
Ms. Madeliene Elaine Gainers, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 660 S. Euclid Avenue, Washington Univ Med Ctr/div Of Dermatology, St Louis, MO 63110 Phone: 314-454-8622 Fax: 314-454-5928 |